Drugs & Clinical Trials

Researchers Say “No-No” to the Thought of Painkillers Preventing Alzheimer’s

April 30, 2007 | By Navdeep Johal | Share, Save, and Bookmark | 2 Comments

Drugs_Clinical_Trials2.jpgTwo new studies, first appeared in the British Medical Journal (BMJ), while the second published in the latest issue of the Neurology journal disputed the belief that commonly used painkillers help prevent Alzheimer’s disease.

The first study in BMJ looked at over 6,000 women. The other in Neurology looked at 2,000 with a family history of Alzheimer’s disease.

The study was conducted by research teams at the Johns Hopkins School of Medicine and Brigham and Women’s Hospital which followed 2,100 people aged over 70. None of them had signs of dementia at the beginning of the study. Participants were given doses of aspirin, naproxen, celecoxib or placebo for four years.

All participants, over period of time, were asked to complete tasks designed to test memory and were also checked for signs of dementia. Researchers found no difference between two groups - placebo and controlled groups. Thus, researchers announced that aspirin and other non-steroidal anti-inflammatory drugs (NSAIDs) have no effect in preventing the onset of dementia and Alzheimer’s.

Researcher’s, however, said that another NSAID, ibuprofen (Advil, Motrin), had been shown to dissolve away protein clumps in the brain that are linked to Alzheimer’s disease. But, they advised not to take aspirin or ibuprofen to try to protect against dementia or Alzheimer’s as they can cause dangerous side-effects, including stomach ulcers and kidney problems.

Dr. Susanne Sorenesen, head of research at the Alzheimer’s Society said, “There is nothing to suggest that painkillers reduce the onset of Alzheimer’s or other types of dementia.” She advised that the best way for reducing the risks of Alzheimer’s is a healthy lifestyle, with regular exercise and a balanced diet. She also added that a healthy heart leads to a healthy mind.

References

Lyketsos CG et al. Naproxen and celecoxib do not prevent AD in early results from a randomized controlled trial. Neurology 2007;68.

Kang JH et al. Low dose aspirin and cognitive function in the women’s health study cognitive cohort. BMJ. 2007.

Related Articles


2 Comments

You can follow any responses to this article through the RSS 2.0 feed. You can leave a response, or trackback from your own site.

Trackbacks


Leave a Reply

Subscribe Without Commenting

Monday, October 13, 2008

Advertisement

Sponsored Links

Neuroscience & Neurology

September 12, 2008 | 1 Comment | By Jared Tanner, MS

Physiological Effects of Alcohol Consumption

More In Neuroscience & Neurology


Neuroscience & Neurology

Opinion

October 07, 2008 | 0 Comments | By J. R. White

China’s Tainted Reputation

More In Opinion


Opinion

Psychiatry & Psychology

October 01, 2008 | 2 Comments | By RD, MD

Sleep Deprivation, Behavior, and the Young

More In Psychiatry & Psychology